Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/6/2018
Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China
2/6/2018
CFDA Vice Minister SUN Xianze to Leave the Agency
2/6/2018
Pfizer, DL Medicine Enter Drug Discovery Partnership
2/6/2018
BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for I...
2/6/2018
China to Step Up Surveillance of Online Drug Sales
2/6/2018
South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...
2/5/2018
Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...
2/5/2018
Heads of CFDA and the Bitish Medicines and Healthcare Products Regulat...
2/5/2018
More Provincial Governments Liberalize Non-essential Drug Use in Prima...
2/2/2018
Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...
2/2/2018
Fosun-backed Shanghai Henlius Biotech Plans IPO in Hong Kong
2/2/2018
AstraZeneca Counts on China and Anticancer Sales for Renewed Growth
2/2/2018
This Is Why Chinese Companies Are Suddenly Targeting Australian Health...
2/2/2018
Puma Biotech and CANbridge Enter Exclusive Licensing for NERLYNX (nera...
2/2/2018
Roche CEO Considers China Business "A Large Focus"
2/2/2018
Shanghai Pharma Completes Acquisition of Cardinal Health's China Busin...
2/2/2018
Recent Executive Moves
2/2/2018
Four Central Government Agencies Issue Joint Notice for Centralized Pr...
2/1/2018
Lundbeck Launches PD Drug Azilect in China
1/31/2018
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...
1/31/2018
CJ Healthcare Licenses EPO Biosimilar to NCPC GeneTech
1/31/2018
Financial-related Company News in Brief
1/31/2018
Light at the End of Tunnel in the Supposedly Hopeful Year of the "...
1/31/2018
Novartis Launches Asthma Drug Xolair (omalizumab) in China
1/31/2018
Lee's Subsidiary Granted Clinical Trial Approval in Three Separate Can...
1/30/2018
Why Most Small Players May Not Survive China's Pharmaceutical Industry...
1/30/2018
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing C...
1/30/2018
TLC, Jixi Biotech to Set Up a JV for the Chinese Market
1/30/2018
CASI Pharma Acquires ANDA Portfolio From Sandoz
1/30/2018
CFDA Lays Out Eight Major Food and Drug Regulatory Tasks in 2018
Page:
349
/
789
Total number of articles:
23668
:
[First]
[<<]
[347]
[348]
[349]
[350]
[351]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit